Seeing Is Believing
Currently out of the existing stock ratings of Robert Jones, 27 are a HOLD (33.75%), 6 are a SELL (7.5%), 47 are a BUY (58.75%).
Analyst Robert Jones, carries an average stock price target met ratio of 79.44% that have a potential upside of 21.96% achieved within 350 days. Previously, Robert Jones worked at BMO.
Robert Jones’s has documented 177 price targets and ratings displayed on 24 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ALGN, Align Technology at 27-Oct-2023.
Analyst best performing recommendations are on ANTM (ANTHEM).
The best stock recommendation documented was for XRAY (DENTSPLY SIRONA) at 4/7/2020. The price target of $40 was fulfilled within 2 days with a profit of $2.81 (7.56%) receiving and performance score of 37.78.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$215
$40.04 (22.89%)
$187
1 years 7 months 27 days ago
(07-Aug-2023)
13/14 (92.86%)
$28.91 (15.54%)
633
Hold
$190
$15.04 (8.60%)
$176
1 years 8 months ago
(03-Aug-2023)
8/8 (100%)
$-0.86 (-0.45%)
433
Buy
$220
$45.04 (25.74%)
$213
1 years 8 months ago
(03-Aug-2023)
11/17 (64.71%)
$29.14 (15.27%)
326
Buy
$215
$40.04 (22.89%)
$200
1 years 8 months ago
(03-Aug-2023)
6/8 (75%)
$24.14 (12.65%)
220
Buy
$225
$50.04 (28.60%)
$184
1 years 8 months 2 days ago
(01-Aug-2023)
11/12 (91.67%)
$36.39 (19.29%)
557
What Year was the first public recommendation made by Robert Jones?